Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression
Biomedical Materials · 2024
DOI: 10.1088/1748-605x/ad1dfc ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2024. Verfasst von Qusay S Atwan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq. Hauptthemen laut MEDLINE: Curcumin, Nanoparticles, Colorectal Neoplasms, MicroRNAs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Curcumin (Cur) possesses remarkable pharmacological properties, including cardioprotective, neuroprotective, antimicrobial, and anticancer activities. However, the utilization of Cur in pharmaceuticals faces constraints owing to its inadequate water solubility and limited bioavailability. To overcome these hurdles, there has been notable focus on exploring innovative formulations, with nanobiotechnology emerging as a promising avenue to enhance the therapeutic effectiveness of these complex compounds. We report a novel safe, effective method for improving the incorporation of anticancer curcumin to induce apoptosis by reducing the expression levels of miR20a and miR21. The established method features three aspects that, to our knowledge, have not been formally verified: (1) use of a novel formula to incorporate curcumin, (2) use of all biocompatible biodegradable materials to produce this formula without leaving harmful residues, and (3) an incorporation process at temperatures of approximately 50 °C. The formula was prepared from lecithin (LE), and chitosan (CH) with an eco-friendly emulsifying agent and olive oil as the curcumin solvent. The formula was converted to nanoscale through ultrasonication and probe sonication at a frequency of 20 kHz. Transmission electron microscopy showed that the nano formula was spherical in shape with sizes ranging between 49.7 nm in diameter and negative zeta potentials ranging from 28 to 34 mV. Primers miR20a and miR21 were designed for molecular studies. Nearly complete curcumin with an encapsulation efficiency of 91.1% was established using a straight-line equation. The nano formula incorporated with curcumin was used to prepare formulations that exhibited anticancer activities. The apoptosis pathway in cancer cells was activated by the minimum inhibitory concentration of the nano formula. These findings suggest the potential of this nanoformulation as an effective and selective cancer treatment that does not affect the normal cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq.
ORCID-Profile: Qusay S Atwan, Israa Al-Ogaidi
Zitieren
APA
Atwan, Q. S., & Al-Ogaidi, I. (2024). Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression. Biomedical Materials. https://doi.org/10.1088/1748-605x/ad1dfc
Vancouver
Atwan QS, Al-Ogaidi I. Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression. Biomedical Materials. 2024. doi:10.1088/1748-605x/ad1dfc
BibTeX
@article{Atwan2024,
author = {Atwan, Qusay S and Al-Ogaidi, Israa},
title = {Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression},
journal = {Biomedical Materials},
year = {2024},
doi = {10.1088/1748-605x/ad1dfc}
}
EUVIMED